- Home
- CMCL vs ORGO Comparison
CMCL vs ORGO Comparison
Compare CMCL & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CMCL | ORGO |
|---|---|---|
| Founded | 1992 | 1985 |
| Country | Jersey | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 552.3M | 348.6M |
| IPO Year | 2003 | 2016 |
Fundamental Metrics
Financial Performance| Metric | CMCL | ORGO |
|---|---|---|
| Price | $25.84 | $2.51 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $28.00 | $8.50 |
| AVG Volume (30 Days) | 186.9K | ★ 1.4M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.21% | N/A |
| EPS Growth | N/A | ★ 1600.00 |
| EPS | N/A | ★ 0.15 |
| Revenue | N/A | ★ $564,169,000.00 |
| Revenue This Year | $35.51 | N/A |
| Revenue Next Year | N/A | $26.27 |
| P/E Ratio | ★ $10.88 | $15.87 |
| Revenue Growth | N/A | ★ 17.04 |
| 52 Week Low | $12.35 | $2.21 |
| 52 Week High | $38.75 | $7.08 |
Technical Indicators
Market Signals| Indicator | CMCL | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 56.69 | 45.44 |
| Support Level | $23.10 | $2.26 |
| Resistance Level | $26.06 | $2.57 |
| Average True Range (ATR) | 1.16 | 0.16 |
| MACD | 0.55 | 0.06 |
| Stochastic Oscillator | 91.02 | 65.48 |
Price Performance
Historical ComparisonAbout CMCL Caledonia Mining Corporation Plc
Caledonia Mining Corp PLC is a gold exploration, development, and mining company. The company's segment includes Blanket, South Africa, Bilboes Oxide mine, and E&E projects. The company generates the majority of its revenue from the Blanket project. The Blanket Mine is located in the south-west of Zimbabwe and operates at a depth of approximately 750 meters below the surface. The company's project includes Maligreen and Motapa.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.